nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Decreased appetite—Calcitriol—osteoporosis	0.00208	0.00208	CcSEcCtD
Nitazoxanide—Back pain—Zoledronate—osteoporosis	0.00208	0.00208	CcSEcCtD
Nitazoxanide—Feeling abnormal—Alendronate—osteoporosis	0.00207	0.00207	CcSEcCtD
Nitazoxanide—Oedema—Ethinyl Estradiol—osteoporosis	0.00207	0.00207	CcSEcCtD
Nitazoxanide—Loss of consciousness—Pamidronate—osteoporosis	0.00207	0.00207	CcSEcCtD
Nitazoxanide—Muscle spasms—Zoledronate—osteoporosis	0.00206	0.00206	CcSEcCtD
Nitazoxanide—Dry mouth—Risedronate—osteoporosis	0.00206	0.00206	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Alendronate—osteoporosis	0.00206	0.00206	CcSEcCtD
Nitazoxanide—Infection—Ethinyl Estradiol—osteoporosis	0.00206	0.00206	CcSEcCtD
Nitazoxanide—Pain—Calcitriol—osteoporosis	0.00205	0.00205	CcSEcCtD
Nitazoxanide—Constipation—Calcitriol—osteoporosis	0.00205	0.00205	CcSEcCtD
Nitazoxanide—Flatulence—Conjugated Estrogens—osteoporosis	0.00204	0.00204	CcSEcCtD
Nitazoxanide—Hypertension—Pamidronate—osteoporosis	0.00203	0.00203	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Raloxifene—osteoporosis	0.00202	0.00202	CcSEcCtD
Nitazoxanide—Diarrhoea—Etidronic acid—osteoporosis	0.00202	0.00202	CcSEcCtD
Nitazoxanide—Abdominal pain—Estropipate—osteoporosis	0.00202	0.00202	CcSEcCtD
Nitazoxanide—Body temperature increased—Estropipate—osteoporosis	0.00202	0.00202	CcSEcCtD
Nitazoxanide—Feeling abnormal—Ibandronate—osteoporosis	0.00202	0.00202	CcSEcCtD
Nitazoxanide—Tremor—Zoledronate—osteoporosis	0.00201	0.00201	CcSEcCtD
Nitazoxanide—Infection—Risedronate—osteoporosis	0.00201	0.00201	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Ibandronate—osteoporosis	0.002	0.002	CcSEcCtD
Nitazoxanide—Myalgia—Pamidronate—osteoporosis	0.002	0.002	CcSEcCtD
Nitazoxanide—Back pain—Conjugated Estrogens—osteoporosis	0.002	0.002	CcSEcCtD
Nitazoxanide—Epistaxis—Estradiol—osteoporosis	0.002	0.002	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Zoledronate—osteoporosis	0.00199	0.00199	CcSEcCtD
Nitazoxanide—Body temperature increased—Alendronate—osteoporosis	0.00199	0.00199	CcSEcCtD
Nitazoxanide—Abdominal pain—Alendronate—osteoporosis	0.00199	0.00199	CcSEcCtD
Nitazoxanide—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00199	0.00199	CcSEcCtD
Nitazoxanide—Shock—Risedronate—osteoporosis	0.00199	0.00199	CcSEcCtD
Nitazoxanide—Anaemia—Zoledronate—osteoporosis	0.00198	0.00198	CcSEcCtD
Nitazoxanide—Discomfort—Pamidronate—osteoporosis	0.00198	0.00198	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Calcitriol—osteoporosis	0.00196	0.00196	CcSEcCtD
Nitazoxanide—Abdominal pain—Raloxifene—osteoporosis	0.00196	0.00196	CcSEcCtD
Nitazoxanide—Body temperature increased—Raloxifene—osteoporosis	0.00196	0.00196	CcSEcCtD
Nitazoxanide—Malaise—Zoledronate—osteoporosis	0.00194	0.00194	CcSEcCtD
Nitazoxanide—Abdominal pain—Ibandronate—osteoporosis	0.00194	0.00194	CcSEcCtD
Nitazoxanide—Body temperature increased—Ibandronate—osteoporosis	0.00194	0.00194	CcSEcCtD
Nitazoxanide—Syncope—Zoledronate—osteoporosis	0.00193	0.00193	CcSEcCtD
Nitazoxanide—Oedema—Pamidronate—osteoporosis	0.00192	0.00192	CcSEcCtD
Nitazoxanide—Infection—Pamidronate—osteoporosis	0.00191	0.00191	CcSEcCtD
Nitazoxanide—Rhinitis—Estradiol—osteoporosis	0.00191	0.00191	CcSEcCtD
Nitazoxanide—Abdominal pain—Calcitriol—osteoporosis	0.0019	0.0019	CcSEcCtD
Nitazoxanide—Body temperature increased—Calcitriol—osteoporosis	0.0019	0.0019	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Estradiol—osteoporosis	0.00189	0.00189	CcSEcCtD
Nitazoxanide—Shock—Pamidronate—osteoporosis	0.00189	0.00189	CcSEcCtD
Nitazoxanide—Loss of consciousness—Zoledronate—osteoporosis	0.00189	0.00189	CcSEcCtD
Nitazoxanide—Pharyngitis—Estradiol—osteoporosis	0.00189	0.00189	CcSEcCtD
Nitazoxanide—Hypersensitivity—Estropipate—osteoporosis	0.00188	0.00188	CcSEcCtD
Nitazoxanide—Vomiting—Etidronic acid—osteoporosis	0.00188	0.00188	CcSEcCtD
Nitazoxanide—Tachycardia—Pamidronate—osteoporosis	0.00187	0.00187	CcSEcCtD
Nitazoxanide—Rash—Etidronic acid—osteoporosis	0.00186	0.00186	CcSEcCtD
Nitazoxanide—Dermatitis—Etidronic acid—osteoporosis	0.00186	0.00186	CcSEcCtD
Nitazoxanide—Syncope—Conjugated Estrogens—osteoporosis	0.00185	0.00185	CcSEcCtD
Nitazoxanide—Hypertension—Zoledronate—osteoporosis	0.00185	0.00185	CcSEcCtD
Nitazoxanide—Hypersensitivity—Alendronate—osteoporosis	0.00185	0.00185	CcSEcCtD
Nitazoxanide—Headache—Etidronic acid—osteoporosis	0.00185	0.00185	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.00184	0.00184	CcSEcCtD
Nitazoxanide—Asthenia—Estropipate—osteoporosis	0.00183	0.00183	CcSEcCtD
Nitazoxanide—Anorexia—Pamidronate—osteoporosis	0.00183	0.00183	CcSEcCtD
Nitazoxanide—Myalgia—Zoledronate—osteoporosis	0.00183	0.00183	CcSEcCtD
Nitazoxanide—Insomnia—Risedronate—osteoporosis	0.00183	0.00183	CcSEcCtD
Nitazoxanide—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00182	0.00182	CcSEcCtD
Nitazoxanide—Pruritus—Estropipate—osteoporosis	0.00181	0.00181	CcSEcCtD
Nitazoxanide—Discomfort—Zoledronate—osteoporosis	0.00181	0.00181	CcSEcCtD
Nitazoxanide—Asthenia—Alendronate—osteoporosis	0.0018	0.0018	CcSEcCtD
Nitazoxanide—Hypersensitivity—Ibandronate—osteoporosis	0.0018	0.0018	CcSEcCtD
Nitazoxanide—Dry mouth—Zoledronate—osteoporosis	0.00179	0.00179	CcSEcCtD
Nitazoxanide—Pruritus—Alendronate—osteoporosis	0.00178	0.00178	CcSEcCtD
Nitazoxanide—Dyspepsia—Risedronate—osteoporosis	0.00178	0.00178	CcSEcCtD
Nitazoxanide—Constipation—Ethinyl Estradiol—osteoporosis	0.00177	0.00177	CcSEcCtD
Nitazoxanide—Hypersensitivity—Calcitriol—osteoporosis	0.00177	0.00177	CcSEcCtD
Nitazoxanide—Myalgia—Conjugated Estrogens—osteoporosis	0.00176	0.00176	CcSEcCtD
Nitazoxanide—Asthenia—Ibandronate—osteoporosis	0.00176	0.00176	CcSEcCtD
Nitazoxanide—Nausea—Etidronic acid—osteoporosis	0.00175	0.00175	CcSEcCtD
Nitazoxanide—Oedema—Zoledronate—osteoporosis	0.00175	0.00175	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.00175	0.00175	CcSEcCtD
Nitazoxanide—Diarrhoea—Estropipate—osteoporosis	0.00175	0.00175	CcSEcCtD
Nitazoxanide—Infection—Zoledronate—osteoporosis	0.00174	0.00174	CcSEcCtD
Nitazoxanide—Insomnia—Pamidronate—osteoporosis	0.00174	0.00174	CcSEcCtD
Nitazoxanide—Pruritus—Ibandronate—osteoporosis	0.00173	0.00173	CcSEcCtD
Nitazoxanide—Pain—Risedronate—osteoporosis	0.00173	0.00173	CcSEcCtD
Nitazoxanide—Constipation—Risedronate—osteoporosis	0.00173	0.00173	CcSEcCtD
Nitazoxanide—Shock—Zoledronate—osteoporosis	0.00172	0.00172	CcSEcCtD
Nitazoxanide—Diarrhoea—Alendronate—osteoporosis	0.00172	0.00172	CcSEcCtD
Nitazoxanide—Asthenia—Calcitriol—osteoporosis	0.00172	0.00172	CcSEcCtD
Nitazoxanide—Tachycardia—Zoledronate—osteoporosis	0.00171	0.00171	CcSEcCtD
Nitazoxanide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00171	0.00171	CcSEcCtD
Nitazoxanide—Chills—Estradiol—osteoporosis	0.00171	0.00171	CcSEcCtD
Nitazoxanide—Somnolence—Pamidronate—osteoporosis	0.00171	0.00171	CcSEcCtD
Nitazoxanide—Pruritus—Calcitriol—osteoporosis	0.0017	0.0017	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00169	0.00169	CcSEcCtD
Nitazoxanide—Diarrhoea—Raloxifene—osteoporosis	0.00169	0.00169	CcSEcCtD
Nitazoxanide—Dyspepsia—Pamidronate—osteoporosis	0.00169	0.00169	CcSEcCtD
Nitazoxanide—Dizziness—Estropipate—osteoporosis	0.00169	0.00169	CcSEcCtD
Nitazoxanide—Oedema—Conjugated Estrogens—osteoporosis	0.00169	0.00169	CcSEcCtD
Nitazoxanide—Infection—Conjugated Estrogens—osteoporosis	0.00168	0.00168	CcSEcCtD
Nitazoxanide—Diarrhoea—Ibandronate—osteoporosis	0.00168	0.00168	CcSEcCtD
Nitazoxanide—Anorexia—Zoledronate—osteoporosis	0.00167	0.00167	CcSEcCtD
Nitazoxanide—Decreased appetite—Pamidronate—osteoporosis	0.00167	0.00167	CcSEcCtD
Nitazoxanide—Dizziness—Alendronate—osteoporosis	0.00166	0.00166	CcSEcCtD
Nitazoxanide—Shock—Conjugated Estrogens—osteoporosis	0.00166	0.00166	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Risedronate—osteoporosis	0.00165	0.00165	CcSEcCtD
Nitazoxanide—Tachycardia—Conjugated Estrogens—osteoporosis	0.00165	0.00165	CcSEcCtD
Nitazoxanide—Pain—Pamidronate—osteoporosis	0.00164	0.00164	CcSEcCtD
Nitazoxanide—Constipation—Pamidronate—osteoporosis	0.00164	0.00164	CcSEcCtD
Nitazoxanide—Diarrhoea—Calcitriol—osteoporosis	0.00164	0.00164	CcSEcCtD
Nitazoxanide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00164	0.00164	CcSEcCtD
Nitazoxanide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.00164	0.00164	CcSEcCtD
Nitazoxanide—Dizziness—Raloxifene—osteoporosis	0.00164	0.00164	CcSEcCtD
Nitazoxanide—Flatulence—Estradiol—osteoporosis	0.00163	0.00163	CcSEcCtD
Nitazoxanide—Vomiting—Estropipate—osteoporosis	0.00162	0.00162	CcSEcCtD
Nitazoxanide—Dizziness—Ibandronate—osteoporosis	0.00162	0.00162	CcSEcCtD
Nitazoxanide—Rash—Estropipate—osteoporosis	0.00161	0.00161	CcSEcCtD
Nitazoxanide—Dermatitis—Estropipate—osteoporosis	0.00161	0.00161	CcSEcCtD
Nitazoxanide—Anorexia—Conjugated Estrogens—osteoporosis	0.00161	0.00161	CcSEcCtD
Nitazoxanide—Back pain—Estradiol—osteoporosis	0.0016	0.0016	CcSEcCtD
Nitazoxanide—Headache—Estropipate—osteoporosis	0.0016	0.0016	CcSEcCtD
Nitazoxanide—Vomiting—Alendronate—osteoporosis	0.0016	0.0016	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.0016	0.0016	CcSEcCtD
Nitazoxanide—Abdominal pain—Risedronate—osteoporosis	0.0016	0.0016	CcSEcCtD
Nitazoxanide—Body temperature increased—Risedronate—osteoporosis	0.0016	0.0016	CcSEcCtD
Nitazoxanide—Muscle spasms—Estradiol—osteoporosis	0.00159	0.00159	CcSEcCtD
Nitazoxanide—Rash—Alendronate—osteoporosis	0.00159	0.00159	CcSEcCtD
Nitazoxanide—Insomnia—Zoledronate—osteoporosis	0.00159	0.00159	CcSEcCtD
Nitazoxanide—Dermatitis—Alendronate—osteoporosis	0.00158	0.00158	CcSEcCtD
Nitazoxanide—Feeling abnormal—Pamidronate—osteoporosis	0.00158	0.00158	CcSEcCtD
Nitazoxanide—Headache—Alendronate—osteoporosis	0.00158	0.00158	CcSEcCtD
Nitazoxanide—Vomiting—Raloxifene—osteoporosis	0.00157	0.00157	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Pamidronate—osteoporosis	0.00157	0.00157	CcSEcCtD
Nitazoxanide—Rash—Raloxifene—osteoporosis	0.00156	0.00156	CcSEcCtD
Nitazoxanide—Dermatitis—Raloxifene—osteoporosis	0.00156	0.00156	CcSEcCtD
Nitazoxanide—Somnolence—Zoledronate—osteoporosis	0.00156	0.00156	CcSEcCtD
Nitazoxanide—Vomiting—Ibandronate—osteoporosis	0.00156	0.00156	CcSEcCtD
Nitazoxanide—Tremor—Estradiol—osteoporosis	0.00155	0.00155	CcSEcCtD
Nitazoxanide—Headache—Raloxifene—osteoporosis	0.00155	0.00155	CcSEcCtD
Nitazoxanide—Rash—Ibandronate—osteoporosis	0.00154	0.00154	CcSEcCtD
Nitazoxanide—Dermatitis—Ibandronate—osteoporosis	0.00154	0.00154	CcSEcCtD
Nitazoxanide—Dyspepsia—Zoledronate—osteoporosis	0.00154	0.00154	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.00154	0.00154	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Estradiol—osteoporosis	0.00154	0.00154	CcSEcCtD
Nitazoxanide—Headache—Ibandronate—osteoporosis	0.00153	0.00153	CcSEcCtD
Nitazoxanide—Insomnia—Conjugated Estrogens—osteoporosis	0.00153	0.00153	CcSEcCtD
Nitazoxanide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00153	0.00153	CcSEcCtD
Nitazoxanide—Vomiting—Calcitriol—osteoporosis	0.00152	0.00152	CcSEcCtD
Nitazoxanide—Decreased appetite—Zoledronate—osteoporosis	0.00152	0.00152	CcSEcCtD
Nitazoxanide—Nausea—Estropipate—osteoporosis	0.00152	0.00152	CcSEcCtD
Nitazoxanide—Abdominal pain—Pamidronate—osteoporosis	0.00152	0.00152	CcSEcCtD
Nitazoxanide—Body temperature increased—Pamidronate—osteoporosis	0.00152	0.00152	CcSEcCtD
Nitazoxanide—Rash—Calcitriol—osteoporosis	0.00151	0.00151	CcSEcCtD
Nitazoxanide—Dermatitis—Calcitriol—osteoporosis	0.00151	0.00151	CcSEcCtD
Nitazoxanide—Headache—Calcitriol—osteoporosis	0.0015	0.0015	CcSEcCtD
Nitazoxanide—Somnolence—Conjugated Estrogens—osteoporosis	0.0015	0.0015	CcSEcCtD
Nitazoxanide—Pain—Zoledronate—osteoporosis	0.0015	0.0015	CcSEcCtD
Nitazoxanide—Constipation—Zoledronate—osteoporosis	0.0015	0.0015	CcSEcCtD
Nitazoxanide—Nausea—Alendronate—osteoporosis	0.00149	0.00149	CcSEcCtD
Nitazoxanide—Malaise—Estradiol—osteoporosis	0.00149	0.00149	CcSEcCtD
Nitazoxanide—Hypersensitivity—Risedronate—osteoporosis	0.00149	0.00149	CcSEcCtD
Nitazoxanide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00149	0.00149	CcSEcCtD
Nitazoxanide—Asthenia—Ethinyl Estradiol—osteoporosis	0.00149	0.00149	CcSEcCtD
Nitazoxanide—Syncope—Estradiol—osteoporosis	0.00148	0.00148	CcSEcCtD
Nitazoxanide—Nausea—Raloxifene—osteoporosis	0.00147	0.00147	CcSEcCtD
Nitazoxanide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00147	0.00147	CcSEcCtD
Nitazoxanide—Pruritus—Ethinyl Estradiol—osteoporosis	0.00146	0.00146	CcSEcCtD
Nitazoxanide—Nausea—Ibandronate—osteoporosis	0.00145	0.00145	CcSEcCtD
Nitazoxanide—Loss of consciousness—Estradiol—osteoporosis	0.00145	0.00145	CcSEcCtD
Nitazoxanide—Asthenia—Risedronate—osteoporosis	0.00145	0.00145	CcSEcCtD
Nitazoxanide—Feeling abnormal—Zoledronate—osteoporosis	0.00144	0.00144	CcSEcCtD
Nitazoxanide—Pain—Conjugated Estrogens—osteoporosis	0.00144	0.00144	CcSEcCtD
Nitazoxanide—Constipation—Conjugated Estrogens—osteoporosis	0.00144	0.00144	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Zoledronate—osteoporosis	0.00143	0.00143	CcSEcCtD
Nitazoxanide—Hypertension—Estradiol—osteoporosis	0.00143	0.00143	CcSEcCtD
Nitazoxanide—Pruritus—Risedronate—osteoporosis	0.00143	0.00143	CcSEcCtD
Nitazoxanide—Nausea—Calcitriol—osteoporosis	0.00142	0.00142	CcSEcCtD
Nitazoxanide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00142	0.00142	CcSEcCtD
Nitazoxanide—Hypersensitivity—Pamidronate—osteoporosis	0.00141	0.00141	CcSEcCtD
Nitazoxanide—Myalgia—Estradiol—osteoporosis	0.00141	0.00141	CcSEcCtD
Nitazoxanide—Discomfort—Estradiol—osteoporosis	0.00139	0.00139	CcSEcCtD
Nitazoxanide—Abdominal pain—Zoledronate—osteoporosis	0.00139	0.00139	CcSEcCtD
Nitazoxanide—Body temperature increased—Zoledronate—osteoporosis	0.00139	0.00139	CcSEcCtD
Nitazoxanide—Diarrhoea—Risedronate—osteoporosis	0.00138	0.00138	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00138	0.00138	CcSEcCtD
Nitazoxanide—Dry mouth—Estradiol—osteoporosis	0.00138	0.00138	CcSEcCtD
Nitazoxanide—Asthenia—Pamidronate—osteoporosis	0.00138	0.00138	CcSEcCtD
Nitazoxanide—Dizziness—Ethinyl Estradiol—osteoporosis	0.00137	0.00137	CcSEcCtD
Nitazoxanide—Pruritus—Pamidronate—osteoporosis	0.00136	0.00136	CcSEcCtD
Nitazoxanide—Oedema—Estradiol—osteoporosis	0.00135	0.00135	CcSEcCtD
Nitazoxanide—Infection—Estradiol—osteoporosis	0.00134	0.00134	CcSEcCtD
Nitazoxanide—Dizziness—Risedronate—osteoporosis	0.00133	0.00133	CcSEcCtD
Nitazoxanide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.00133	0.00133	CcSEcCtD
Nitazoxanide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00133	0.00133	CcSEcCtD
Nitazoxanide—Shock—Estradiol—osteoporosis	0.00133	0.00133	CcSEcCtD
Nitazoxanide—Tachycardia—Estradiol—osteoporosis	0.00132	0.00132	CcSEcCtD
Nitazoxanide—Vomiting—Ethinyl Estradiol—osteoporosis	0.00132	0.00132	CcSEcCtD
Nitazoxanide—Diarrhoea—Pamidronate—osteoporosis	0.00131	0.00131	CcSEcCtD
Nitazoxanide—Rash—Ethinyl Estradiol—osteoporosis	0.00131	0.00131	CcSEcCtD
Nitazoxanide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.0013	0.0013	CcSEcCtD
Nitazoxanide—Headache—Ethinyl Estradiol—osteoporosis	0.0013	0.0013	CcSEcCtD
Nitazoxanide—Hypersensitivity—Zoledronate—osteoporosis	0.00129	0.00129	CcSEcCtD
Nitazoxanide—Vomiting—Risedronate—osteoporosis	0.00128	0.00128	CcSEcCtD
Nitazoxanide—Rash—Risedronate—osteoporosis	0.00127	0.00127	CcSEcCtD
Nitazoxanide—Dermatitis—Risedronate—osteoporosis	0.00127	0.00127	CcSEcCtD
Nitazoxanide—Dizziness—Pamidronate—osteoporosis	0.00127	0.00127	CcSEcCtD
Nitazoxanide—Headache—Risedronate—osteoporosis	0.00126	0.00126	CcSEcCtD
Nitazoxanide—Asthenia—Zoledronate—osteoporosis	0.00126	0.00126	CcSEcCtD
Nitazoxanide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00124	0.00124	CcSEcCtD
Nitazoxanide—Pruritus—Zoledronate—osteoporosis	0.00124	0.00124	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.00123	0.00123	CcSEcCtD
Nitazoxanide—Nausea—Ethinyl Estradiol—osteoporosis	0.00123	0.00123	CcSEcCtD
Nitazoxanide—Insomnia—Estradiol—osteoporosis	0.00122	0.00122	CcSEcCtD
Nitazoxanide—Vomiting—Pamidronate—osteoporosis	0.00122	0.00122	CcSEcCtD
Nitazoxanide—Asthenia—Conjugated Estrogens—osteoporosis	0.00121	0.00121	CcSEcCtD
Nitazoxanide—Rash—Pamidronate—osteoporosis	0.00121	0.00121	CcSEcCtD
Nitazoxanide—Dermatitis—Pamidronate—osteoporosis	0.00121	0.00121	CcSEcCtD
Nitazoxanide—Headache—Pamidronate—osteoporosis	0.0012	0.0012	CcSEcCtD
Nitazoxanide—Somnolence—Estradiol—osteoporosis	0.0012	0.0012	CcSEcCtD
Nitazoxanide—Diarrhoea—Zoledronate—osteoporosis	0.0012	0.0012	CcSEcCtD
Nitazoxanide—Nausea—Risedronate—osteoporosis	0.0012	0.0012	CcSEcCtD
Nitazoxanide—Pruritus—Conjugated Estrogens—osteoporosis	0.00119	0.00119	CcSEcCtD
Nitazoxanide—Dyspepsia—Estradiol—osteoporosis	0.00119	0.00119	CcSEcCtD
Nitazoxanide—Decreased appetite—Estradiol—osteoporosis	0.00117	0.00117	CcSEcCtD
Nitazoxanide—Dizziness—Zoledronate—osteoporosis	0.00116	0.00116	CcSEcCtD
Nitazoxanide—Pain—Estradiol—osteoporosis	0.00115	0.00115	CcSEcCtD
Nitazoxanide—Constipation—Estradiol—osteoporosis	0.00115	0.00115	CcSEcCtD
Nitazoxanide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00115	0.00115	CcSEcCtD
Nitazoxanide—Nausea—Pamidronate—osteoporosis	0.00114	0.00114	CcSEcCtD
Nitazoxanide—Dizziness—Conjugated Estrogens—osteoporosis	0.00112	0.00112	CcSEcCtD
Nitazoxanide—Vomiting—Zoledronate—osteoporosis	0.00111	0.00111	CcSEcCtD
Nitazoxanide—Feeling abnormal—Estradiol—osteoporosis	0.00111	0.00111	CcSEcCtD
Nitazoxanide—Rash—Zoledronate—osteoporosis	0.00111	0.00111	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Estradiol—osteoporosis	0.0011	0.0011	CcSEcCtD
Nitazoxanide—Dermatitis—Zoledronate—osteoporosis	0.0011	0.0011	CcSEcCtD
Nitazoxanide—Headache—Zoledronate—osteoporosis	0.0011	0.0011	CcSEcCtD
Nitazoxanide—Vomiting—Conjugated Estrogens—osteoporosis	0.00107	0.00107	CcSEcCtD
Nitazoxanide—Abdominal pain—Estradiol—osteoporosis	0.00107	0.00107	CcSEcCtD
Nitazoxanide—Body temperature increased—Estradiol—osteoporosis	0.00107	0.00107	CcSEcCtD
Nitazoxanide—Rash—Conjugated Estrogens—osteoporosis	0.00106	0.00106	CcSEcCtD
Nitazoxanide—Dermatitis—Conjugated Estrogens—osteoporosis	0.00106	0.00106	CcSEcCtD
Nitazoxanide—Headache—Conjugated Estrogens—osteoporosis	0.00106	0.00106	CcSEcCtD
Nitazoxanide—Nausea—Zoledronate—osteoporosis	0.00104	0.00104	CcSEcCtD
Nitazoxanide—Nausea—Conjugated Estrogens—osteoporosis	0.001	0.001	CcSEcCtD
Nitazoxanide—Hypersensitivity—Estradiol—osteoporosis	0.000995	0.000995	CcSEcCtD
Nitazoxanide—Asthenia—Estradiol—osteoporosis	0.000969	0.000969	CcSEcCtD
Nitazoxanide—Pruritus—Estradiol—osteoporosis	0.000956	0.000956	CcSEcCtD
Nitazoxanide—Diarrhoea—Estradiol—osteoporosis	0.000924	0.000924	CcSEcCtD
Nitazoxanide—Dizziness—Estradiol—osteoporosis	0.000893	0.000893	CcSEcCtD
Nitazoxanide—Vomiting—Estradiol—osteoporosis	0.000859	0.000859	CcSEcCtD
Nitazoxanide—Rash—Estradiol—osteoporosis	0.000852	0.000852	CcSEcCtD
Nitazoxanide—Dermatitis—Estradiol—osteoporosis	0.000851	0.000851	CcSEcCtD
Nitazoxanide—Headache—Estradiol—osteoporosis	0.000846	0.000846	CcSEcCtD
Nitazoxanide—Nausea—Estradiol—osteoporosis	0.000802	0.000802	CcSEcCtD
